Active, not recruitingNCT07103733

PRIMARY Ancillary Substudy

Annetine GelijnsMultiple US sitesView on ClinicalTrials.gov

AI Description

The PRIMARY trial (NCT05051033), which compares mitral valve repair (MVr) to transcatheter-edge-to-edge-repair (TEER), offers a platform for conducting mechanistic studies to develop early insights into the pathophysiological processes by which mitral valve prolapse (MVP) can impact left ventricular (LV) myocardial structure and function, and, thereby, predispose to arrhythmias and sudden death. Such insights are key to identifying interventions to reduce the long-term sequelae of heart failure (HF) and arrhythmias, as well as delineate optimal therapeutic approaches for different patient sub-groups.

Report inaccurate information

Who can join
adult, older adult
Participants
250
Expected completion
2027-06-30
Funded by
other

Conditions studied

Left Ventricular Fibrosis, Mitral Valve Prolapse, Ventricular Arrhythmias

What is being tested

  • DEVICE: ZioPatch Monitoring
  • PROCEDURE: Cardiac Magnetic Resonance Imaging
  • PROCEDURE: Myocardial Tissue Biopsy

What it measures

  • Presence of Myocardial Fibrosis, Myocardial fibrosis is the buildup of excess fibrous connective tissue in the heart muscle often resulting from chronic injury or stress. It can impair the heart's ability to contract and relax properly leading to reduced cardiac function., 1 year post index procedure.
  • Presence of Ventricular Arrythmia, A ventricular arrhythmia is an abnormal heart rhythm that starts in the lower chambers of the heart (the ventricles). It can cause the heart to beat too fast, which may reduce blood flow to the body and, in some cases, be life-threatening., 1 year post index procedure.
  • Proteomics, Proteomics is the large-scale study of proteins, which are essential molecules that carry out most functions in the body. By analyzing proteins in tissues or fluids, scientists can better understand diseases, identify biomarkers, and discover new treatment targets., 1 year post index procedure.

Working with

National Heart, Lung, and Blood Institute (NHLBI)

Centers Participating

These centers are participating in this study. Reach out to them directly to learn more.

Data Sources and Methodology

Registry entry updated 2026-09-08

Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.

If you would rather we did it with you, call us on (656) 206-4686.